从暴露到致病:对SCCP诱导的毒性和潜在的分子机制进行了批判性审查
Liyong Kou1, Hong Qi2, Yi Jiang3
1Department of General Practice, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu 214000, People's Republic of China.
Ecotoxicology and environmental safety
|September 20, 2025
概括
短链甲 (SCCP) 是人类中发现的持久性污染物,具有器官损伤和癌症等风险. 健康风险评估对于管理这些环境污染物至关重要.
科学领域:
- 环境化学环境化学
- 毒理学 毒理学 毒理学
- 公共卫生 公共卫生
背景情况:
- 短链化 (SCCP) 是一种工业化学品,具有很高的稳定性,但涉及环境持久性.
- 由于生物积累,远程运输和毒性,SCCPs在斯德哥尔摩公约下被认定为持久有机污染物 (POP).
- 尽管存在全球限制,但SCCP的生产和使用在一些地区仍然存在,导致人类广泛暴露.
研究的目的:
- 综合审查SCCPs的暴露途径,人类积累和毒理机制.
- 专注于SCCP对各种器官系统和代谢过程的特定毒性影响.
- 突出慢性SCCP暴露对公共健康的影响,并提出未来研究方向.
主要方法:
- 对SCCP暴露,毒性和人类存在的现有研究的文献综述.
- 对与疾病生物标志物相关联的SCCP水平的流行病学数据的分析.
- 综合有关毒性机制的信息,包括对代谢障碍和信号通路的影响.
主要成果:
- 在人体样本中无处不在检测到SCCP,包括血液,头发和带.
- 对SCCP的暴露与代谢障碍,肝脏和脏毒性以及癌症风险增加有关.
- 有证据表明,血清SCCP水平与某些疾病的生物标志物之间存在相关性,这表明潜在的健康危害.
结论:
- 长期暴露于SCCP引起了全球重大公共卫生问题,需要进行全面的风险评估.
- 未来的研究应该整合人类暴露学,计算毒理学和有机物技术,用于预警和管理.
- 作为持久性有机污染物,SCCP的有效全球管理对于减轻健康风险至关重要.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
720
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
15.3K
相关概念视频
Toxic Reactions: Overview
1.8K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.8K
Mutagenicity and Carcinogenicity
1.9K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.9K
